Javascript must be enabled to continue!
Viral Pneumonia Attenuates Adenylate Cyclase But Not Beta-Adrenergic Receptors in Murine Lung
View through CrossRef
Abstract
Respiratory infections provoke increased airway reactivity in both asthmatic and otherwise healthy subjects in part through impaired beta-adrenergic relaxation of bronchial and tracheal muscle. The precise mechanism remains obscure, but some studies report a decrease in the number of beta-adrenergic receptors. The present study was designed to assess the effect of viral respiratory infection with influenza A on lung beta-adrenergic receptors and adenylate cyclase activation in mice under two separate protocols. First, to determine whether changes are due to a local or systemic effect, we compared mice with influenza infections limited to the upper respiratory tract to mice with infection of the total respiratory tract. Four days after upper respiratory tract infection there were no changes in either isoproterenol- or NaF-stimulated adenylate cyclase activity. In contrast, there was an 82% decrease in isoproterenol- and a 25% decrease in NaF-stimulated adenylate cyclase activity on the fourth day after total respiratory tract infection. There were no changes in beta-adrenergic receptors or receptor coupling to adenylate cyclase with either type of infection. Our second protocol compared acutely infected mice to postrecovery mice. Twelve days after infection the virus was no longer present in the lungs, and adenylate cyclase activity was restored to normal. These data suggest that viral respiratory infection may impair airway function through attenuation of receptor and postreceptor activation of adenylate cyclase activity.
Oxford University Press (OUP)
Title: Viral Pneumonia Attenuates Adenylate Cyclase But Not Beta-Adrenergic Receptors in Murine Lung
Description:
Abstract
Respiratory infections provoke increased airway reactivity in both asthmatic and otherwise healthy subjects in part through impaired beta-adrenergic relaxation of bronchial and tracheal muscle.
The precise mechanism remains obscure, but some studies report a decrease in the number of beta-adrenergic receptors.
The present study was designed to assess the effect of viral respiratory infection with influenza A on lung beta-adrenergic receptors and adenylate cyclase activation in mice under two separate protocols.
First, to determine whether changes are due to a local or systemic effect, we compared mice with influenza infections limited to the upper respiratory tract to mice with infection of the total respiratory tract.
Four days after upper respiratory tract infection there were no changes in either isoproterenol- or NaF-stimulated adenylate cyclase activity.
In contrast, there was an 82% decrease in isoproterenol- and a 25% decrease in NaF-stimulated adenylate cyclase activity on the fourth day after total respiratory tract infection.
There were no changes in beta-adrenergic receptors or receptor coupling to adenylate cyclase with either type of infection.
Our second protocol compared acutely infected mice to postrecovery mice.
Twelve days after infection the virus was no longer present in the lungs, and adenylate cyclase activity was restored to normal.
These data suggest that viral respiratory infection may impair airway function through attenuation of receptor and postreceptor activation of adenylate cyclase activity.
Related Results
Melittin-induced alteration of epidermal adenylate cyclase responses
Melittin-induced alteration of epidermal adenylate cyclase responses
Using an in vitro pig skin-slice incubation system, we investigated the effect of melittin, a phospholipase A2 (PLA2) stimulator, on the adenylate cyclase-cyclic AMP (cAMP) system....
Adenylate‐Cyclase Receptors for Adrenergic Neurotransmitters in Rat Cerebral Cortex
Adenylate‐Cyclase Receptors for Adrenergic Neurotransmitters in Rat Cerebral Cortex
The response of adenylate cyclase systems to putative neurotransmitter agents has been studied in cell‐free preparations from various brain regions of young adult rats. Homogenates...
The role of zinc status in altered cardiac adenylate cyclase activity in diabetic rats
The role of zinc status in altered cardiac adenylate cyclase activity in diabetic rats
Abstract. Zinc deficiency and altered myocardial adenylate cyclase activity commonly occur in diabetes. To determine whether the zinc intake of the animal can account for the alter...
Decreased isoproterenol-induced "down"-regulation of beta-adrenergic receptors in the myocardium of SHR.
Decreased isoproterenol-induced "down"-regulation of beta-adrenergic receptors in the myocardium of SHR.
The number of cardiac beta-adrenergic receptors and the activity of isoproterenol-stimulated adenylate cyclase are lower in spontaneously hypertensive rats (SHRs) and may account f...
DEVELOPMENTAL AND REGIONAL VARIATIONS IN NEUROTRANSMITTER‐SENSITIVE ADENYLATE CYCLASE SYSTEMS IN CELL‐FREE PREPARATIONS FROM RAT BRAIN
DEVELOPMENTAL AND REGIONAL VARIATIONS IN NEUROTRANSMITTER‐SENSITIVE ADENYLATE CYCLASE SYSTEMS IN CELL‐FREE PREPARATIONS FROM RAT BRAIN
AbstractInvestigations have been carried out on regional and developmental variations in the properties of adenylate cyclase systems in participate preparations from rat brain. EGT...
The dynamics of LH-induced desensitization of adenylate cyclase and LH receptor internalization in rat Leydig cells at physiological levels of LH
The dynamics of LH-induced desensitization of adenylate cyclase and LH receptor internalization in rat Leydig cells at physiological levels of LH
ABSTRACT
The LH-induced desensitization of adenylate cyclase and LH receptor internalization in rat Leydig cells in vitro has been investigated using sub-physiolo...
Cardiac beta-adrenergic receptors in salt-dependent genetic hypertension.
Cardiac beta-adrenergic receptors in salt-dependent genetic hypertension.
The pattern of cardiac beta-adrenergic receptor changes in different hypertrophy models varies according to the pathophysiology. In salt-sensitive Dahl rats, high dietary salt inta...
Beta-adrenergic blocker treatment for COVID-19
Beta-adrenergic blocker treatment for COVID-19
More than 2.5 million people were affected by COVID-19 and it had caused around 175000 deaths as of April 23, 2020. Currently no effective treatment option is present for COVID-19 ...

